SPINK1 and PRSS1 mutations in benign pancreatic hyperenzymemia

Pancreas

Volumn 37, Issue 1, 2008, Pages 31-35

  Gullo, Lucio ^a   Laghi, Luigi ^b   Migliori, Marina ^a   Lucrezio, Laura ^a   Bianchi, Paolo ^b   Randolph, Ann E ^b   Mantovani, Vilma ^c   Bastagli, Luciana ^a   Pezzilli, Raffaele ^a   Malesci, Alberto ^b,d  

^a UNIVERSITY OF BOLOGNA   (Italy)

^b HUMANITAS CLINICAL AND RESEARCH CENTER   (Italy)

^c UNIVERSITY OF BOLOGNA   (Italy)

^d UNIVERSITY OF MILAN   (Italy)

Author keywords

Benign pancreatic hyperenzymemia; Chronic pancreatitis; Hereditary pancreatitis; PRSS1 mutations; SPINK1 mutations

Indexed keywords

ADENINE; ALANINE; ARGININE; ASPARAGINE; CYTOSINE; GLYCINE; GUANINE; PROLINE; SERINE; VALINE; AMYLASE; CARRIER PROTEIN; ISOAMYLASE; PNLIP PROTEIN, HUMAN; PRSS1 PROTEIN, HUMAN; SPINK1 PROTEIN, HUMAN; TRIACYLGLYCEROL LIPASE; TRYPSINOGEN;

ADOLESCENT; ADULT; AGED; AMINO ACID SUBSTITUTION; ARTICLE; BENIGN PANCREATIC HYPERENZYMEMIA; CHILD; DNA SEQUENCE; EXON; FAMILIAL DISEASE; FEMALE; GENE MUTATION; GENE SEGREGATION; GENETIC VARIABILITY; GERM LINE; HEREDITY; HUMAN; HUMAN GENOME; INBORN ERROR OF METABOLISM; INTRON; MAJOR CLINICAL STUDY; MALE; MUTATIONAL ANALYSIS; PANCREATITIS; PEDIGREE ANALYSIS; PRIORITY JOURNAL; PRSS1 GENE; SCHOOL CHILD; SPINK1 GENE; BLOOD; ENZYMOLOGY; GENETIC PREDISPOSITION; GENETICS; MIDDLE AGED; MOLECULAR GENETICS; MUTATION; NUCLEOTIDE SEQUENCE; PANCREAS; PANCREAS DISEASE; SYNDROME;

ADOLESCENT; ADULT; AGED; AMYLASES; BASE SEQUENCE; CARRIER PROTEINS; CHILD; EXONS; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; INTRONS; ISOAMYLASE; LIPASE; MALE; MIDDLE AGED; MOLECULAR SEQUENCE DATA; MUTATION; PANCREAS; PANCREATIC DISEASES; PANCREATITIS; SYNDROME; TRYPSINOGEN;

EID: 49649112665     PISSN: 08853177     EISSN: None     Source Type: Journal    
DOI: 10.1097/MPA.0b013e31816172b7     Document Type: Article

References (23)

1. Gullo L. Chronic nonpathological hyperamylasemia of pancreatic origin. Gastroenterology. 1996;110:1905-1908.
2. Gullo L, Ventrucci M, Barakat B, et al. Effect of secretin on serum pancreatic enzymes and on the Wirsung duct in chronic nonpathological pancreatic hyperenzymemia. Pancreatology. 2003;3:191-194.
3. Gullo L. Familial pancreatic hyperenzymemia. Pancreas. 2000;20:158-160.
4. Gullo L. Day-to-day variations of serum pancreatic enzymes in benign pancreatic hyperenzymemia. Clin Gastroenterol Hepatol. 2007;5: 70-74.
5. Gullo L, Migliori M. Benign pancreatic hyperenzymemia in children. Eur J Pediatr. 2007;166:125-129.
6. Gullo L. Benign pancreatic hyperenzymemia. Dig Liver Dis. 2007;39:698-702.
7. Whitcomb DC, Gorry MC, Preston RA, et al. Hereditary pancreatitis is caused by a mutation in the cationic trypsinogen gene. Nat Genet. 1996;14:141-145.
8. Sharer N, Schwarz M, Malone G, et al. Mutations of the cystic fibrosis gene in patients with chronic pancreatitis. N Engl J Med. 1998;339: 645-652.
9. Cohn JA, Friedman KJ, Noone PG, et al. Relation between mutations of the cystic fibrosis gene and idiopathic pancreatitis. N Engl J Med. 1998;339:653-658.
10. Gaia E, Salacone P, Gallo M, et al. Germline mutations in CFTR and PSTI genes in chronic pancreatitis patients. Dig Dis Sci. 2002;47:2416-2421.
11. Pezzilli R, Morselli-Labate AM, Mantovani V, et al. Mutations of the CFTR gene in pancreatic disease. Pancreas. 2003;27:332-346.
12. Chen JM, Mercier B, Audrezet MP, et al. Mutations of the pancreatic secretory trypsin inhibitor (PSTI) gene in idiopathic chronic pancreatitis. Gastroenterology. 2001;120:1061-1064.
13. Perri F, Piepoli A, Stanziale P, et al. Mutation analysis of the cystic fibrosis transmembrane conductance regulator (CFTR) gene, the cationic trypsinogen (PRSS1) gene, and the serine protease inhibitor, Kazal type 1 (SPINK1) gene in patients with alcoholic chronic pancreatitis. Eur J Hum Genet. 2003;11:687-692.
14. Witt H, Luck W, Hennies HC, et al. Mutations in the gene encoding the serine protease inhibitor, Kazal type 1 are associated with chronic pancreatitis. Nat Genet. 2000;25:213-216.
15. Gullo L, Mantovani V, Manca M, et al. Mutations of the CFTR gene in idiopathic pancreatic hyperenzymemia. Pancreas. 2005;31:350-352.
16. Pezzilli R, Billi P, Miglioli M, et al. Serum amylase and lipase concentrations and lipase/amylase ratio in assessment of etiology and severity of acute pancreatitis. Dig Dis Sci. 1993;38:1265-1269.
17. Gullo L, Ventrucci M, Tomassetti P, et al. Fecal elastase 1 determination in chronic pancreatitis. Dig Dis Sci. 1999;44:210-213.
18. Whitcomb DC. Value of genetic testing in the management of pancreatitis. Gut. 2004;53:1710-1717.
19. Witt H, Luck W, Becker M. A signal peptide cleavage site mutation in the cationic trypsinogen gene is strongly associated with chronic pancreatitis. Gastroenterology. 1999;117:7-10.
20. Chen J-M, Le Marechal C, Lucas D, et al. "Loss of function" mutations in the cationic trypsinogen gene (PRSS1) may act as a protective factor against pancreatitis. Mol Genet Metab. 2003;79:67-70.
21. Piepoli A, Gentile A, Valvano MR, et al. Lack of association between UGT1a7, UGT1A9, ARP, SPINK1 and CFTR gene polymorphism and pancreatic cancer in Italian patients. World J Gastroenterol. 2006;12:6343-6348.
22. Kuwata K, Hirote M, Sugita H, et al. Genetic mutations in exons 3 and 4 of the pancreatic secretory trypsin inhibitor in patients with pancreatitis. J Gastroenterol. 2001;36:612-618.
23. Kiraly O, Wartmann T, Sahin-Toth M. Missense mutations in pancreatic secretory trypsin inhibitor (SPINK1) cause intracellular retention and degradation. Gut. 2007;56:1433-1438.